drugset / Trial / NCT05546047
A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
A Multicenter, Comparative Safety and Efficacy Study of Acthar gel alone or in combination with oral Tacrolimus to reduce urinary proteinuria in patients with idiopathic DNAJB9 Positive Fibrillary glomerulopathy.
Timeline
- Start
- 2019-03-14
- Primary completion
- 2023-10-27
- Completion
- 2024-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acthar | Peptide | 80 iu | — |
| Comparator | Tacrolimus | Small molecule | 1 mg | Oral |